Circulation · 1986 · 111 citations · 26 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical CardiologyInterventional CardiologyCardiovascular DiseaseCardiovascular PharmacodynamicsCardiovascular PharmacologyCoronary AngiographyCoronary Artery DiseaseIschemic Heart DiseaseCalcitonin Gene-related Peptide PhysiologyCoronary HemodynamicsIsosorbide DinitrateVariant Angina TreatmentVascular Smooth Muscle PharmacologyVascular Smooth Muscle RegulationVascular Smooth Muscle RelaxationVascular Spasm
To investigate the action of calcitonin gene-related peptide (CGRP) on human epicardial coronary arteries, six patients received intracoronary CGRP at doses of 50,100, and 200 ng/min. The effect of CGRP was measured angiographically with a computerized analysis system. A dose-dependent increase in coronary arterial diameter was observed. At the highest dose there were 34%, 7%, 38%, and 40% mean increases in the diameters of the circumflex, proximal, mid, and distal left anterior descending arteries, respectively. No further increase in diameter was found after a subsequent dose of 1 mg intracoronary isosorbide dinitrate. Prior infusion of CGRP did not prevent coronary arterial spasm induced by ergonovine in two patients with variant angina, but a subsequent bolus of CGRP partially relieved the spasm. We propose that CGRP has a role in the regulation of coronary vascular smooth muscle tone.
26
Calcitonin gene-related peptide is a potent vasodilator
Susan D. Brain, T.J. Williams, John R. Tippins et al. · Nature · 1985 · 2.1K citations